COMPOUNDS FOR INHIBITING THE INTERACTION OF SARS-COV2 WITH HUMAN PROTEIN ACE2
- Filing date:
- Status: disponibile a cessione o licenza
- Patent type: Brevetti
- Priority Number: Composti per inibire l'interazione di SARS Cov2 con la proteina ACE2 umana
- Technologic Area: Farmaceutica
- Espacenet https://worldwide.espacenet.com/publicationDetail…
- Assignees: Scuola Superiore Sant'Anna, Istituto Italiano Tecnologia, Università di Milano
- Inventors: Paolo Ciana, Brunialti Electra, Villa Alessandro Maria Giovanni, Angelo Reggiani, Vincenzo Lionetti
The invention concerns the use of DNA aptamers that can shield the SARS-CoV-2 binding site on the cell, and halt the cell-to-cell spreading of coronavirus. The novel oligonucleotide, and the anti-coronavirus strategy based on the protection of the target cell, are innovative technologies that could be developed into a novel COVID-19 therapy that is effective against variants of the virus....more